日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antioxidant Defense Strategies Against Diaporthe eres Infection in Hongyang Kiwifruit

红阳猕猴桃抗病菌感染的抗氧化防御策略

Ling, Lizhen; Yang, Tao; Long, Xiaoqing; Pan, Shengyu; Zhang, Shudong

Interventions for reducing caregiver burden in chronic dyspnea: a meta-analysis

减轻慢性呼吸困难患者照护者负担的干预措施:一项荟萃分析

Liu, Fang; Zhang, Han; Li, Shihan; Wang, Xianshan; Long, Xiaoqing; Liu, Yang

Association between body roundness index and trajectories of depressive symptoms among Chinese middle-aged and older adults: a nationwide cohort study from CHARLS

中国中老年人体型圆润度指数与抑郁症状轨迹的关联:一项来自CHARLS的全国性队列研究

Zhao, Dehua; Long, Xiaoqing; Wang, Jisheng

Impact of an ERAS based nursing program on postoperative recovery in patients undergoing grade IV day surgery: a randomized controlled trial

基于加速康复外科(ERAS)的护理方案对接受IV级日间手术患者术后康复的影响:一项随机对照试验

Liu, Fang; Zhang, Han; Long, Xiaoqing; Li, Caili; Huang, Mingjun

Association between dietary folate intake and severe headache or migraine in adults: a cross-sectional study of the National Health and Nutrition Examination Survey

膳食叶酸摄入量与成人严重头痛或偏头痛之间的关联:一项基于全国健康和营养调查的横断面研究

Zhao, Dehua; Long, Xiaoqing; Wang, Jisheng

Combining the Vaginal Microbiome and Serum Metabolome to Screen for Potential Biomarkers of Early Pregnancy in Cows

结合阴道微生物组和血清代谢组筛选母牛早期妊娠的潜在生物标志物

Luo, Yan; Wang, Zhen; Zhao, Xin; Xing, Jiankang; Chen, Zhiliang; Zhao, Wenxue; Long, Xiaoqing; Zhang, Yanbing; Shao, Yongbin

Pharmacovigilance study of BCR-ABL1 tyrosine kinase inhibitors: a safety analysis of the FDA adverse event reporting system

BCR-ABL1酪氨酸激酶抑制剂的药物警戒研究:FDA不良事件报告系统的安全性分析

Zhao, Dehua; Long, Xiaoqing; Wang, Jisheng

Transporter‑mediated drug‑drug interactions involving poly (ADP‑ribose) polymerase inhibitors (Review)

涉及聚(ADP-核糖)聚合酶抑制剂的转运蛋白介导的药物相互作用(综述)

Zhao, Dehua; Long, Xiaoqing; Wang, Jisheng

Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System

英菲格拉替尼药物警戒研究:FDA不良事件报告系统的安全性分析

Zhao, Dehua; Long, Xiaoqing; Zhou, Jiping; Wang, Jisheng

Dose Adjustment of Poly (ADP‑Ribose) Polymerase Inhibitors in Patients with Hepatic or Renal Impairment

肝肾功能不全患者聚(ADP-核糖)聚合酶抑制剂的剂量调整

Zhao, Dehua; Long, Xiaoqing; Wang, Jisheng